Global Diabetes Situation: Over 1 in 10 Adults Affected, Prevention Is More Urgent Than EverDiabetes has long ceased being a disease confined to affluent nations—it has evolved in...
September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...